Creating a world leader in stem cell research
McEwens double their investment in research with second gift
Four years ago, Rob and Cheryl McEwen established the McEwen Centre for Regenerative Medicine with a $10 million gift. With tremendous foresight and keen sense of the possibility of the future, the McEwens have renewed their commitment to regenerative medicine and stem cell research with a second gift of $10 million. This is the largest cumulative donation to regenerative medicine in Canada.
“We are extremely excited to receive this additional support for stem cell research and regenerative medicine. I believe that it will help us recruit and retain the best scientists in the field. The opportunities that this gift provides will undoubtedly result in major advances in regenerative medicine,” said McEwen Centre Director Dr. Gordon Keller. A leading stem cell researcher, Dr. Keller was recruited from New York’s Mount Sinai School of Medicine following the McEwens’ first $10 million gift. He joined Dr. Rudi von Harsdorf who was recruited from Berlin, Germany to be the Robert R. McEwen Chair in Cardiac Regenerative Medicine. Both researchers are part of an “all-star” complement of 15 scientists who are leaders in regenerative medicine and stem cell research in Canada.
This new funding will support several initiatives at the Centre, including recruiting new talent from around the world with the establishment of a fellowship program; the development of an embryonic stem cell laboratory and imaging facilities; and a program to support the commercialization of discoveries emerging from the McEwen Centre. These projects are part of a 10-year plan to position the centre as a world leader in stem cell research.
These contributions have garnered the attention of new donors, including the St. George’s Society. This past April, the Society presented the McEwens with the St. George’s Society Award of Merit along with $500,000 raised at the Red Rose Ball for the McEwen Centre.
The McEwen Centre for Regenerative Medicine was established in 2003. Its mission is to accelerate the development of better and more effective treatments for life-threatening conditions such as heart disease, diabetes, respiratory disease and spinal cord injury and be a world-renowned centre for regenerative medicine and stem cell biology. |